Free Trial

StrongBox Wealth LLC Reduces Stock Position in Danaher Co. (NYSE:DHR)

Danaher logo with Multi-Sector Conglomerates background

StrongBox Wealth LLC reduced its holdings in Danaher Co. (NYSE:DHR - Free Report) by 25.7% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 11,244 shares of the conglomerate's stock after selling 3,895 shares during the period. StrongBox Wealth LLC's holdings in Danaher were worth $2,581,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in DHR. Fort Pitt Capital Group LLC raised its holdings in shares of Danaher by 3.2% in the 3rd quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate's stock valued at $66,194,000 after purchasing an additional 7,421 shares in the last quarter. Good Life Advisors LLC purchased a new stake in shares of Danaher in the 3rd quarter valued at $217,000. ORG Partners LLC boosted its holdings in shares of Danaher by 1,212.8% in the 4th quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate's stock valued at $636,000 after acquiring an additional 2,559 shares during the last quarter. Harvest Portfolios Group Inc. boosted its holdings in shares of Danaher by 1.2% in the 3rd quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate's stock valued at $56,233,000 after acquiring an additional 2,465 shares during the last quarter. Finally, Stifel Financial Corp boosted its holdings in shares of Danaher by 1.3% in the 3rd quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate's stock valued at $235,583,000 after acquiring an additional 11,216 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on DHR shares. Raymond James lowered their price target on shares of Danaher from $310.00 to $300.00 and set an "outperform" rating on the stock in a report on Wednesday, October 23rd. Bank of America upgraded shares of Danaher from a "neutral" rating to a "buy" rating and set a $290.00 price objective for the company in a research report on Friday, December 13th. Robert W. Baird lowered their target price on shares of Danaher from $278.00 to $277.00 and set an "outperform" rating for the company in a research note on Wednesday, October 23rd. Stifel Nicolaus raised their price objective on shares of Danaher from $250.00 to $265.00 and gave the company a "hold" rating in a research note on Wednesday, October 23rd. Finally, UBS Group reduced their target price on shares of Danaher from $309.00 to $305.00 and set a "buy" rating on the stock in a report on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, Danaher currently has an average rating of "Moderate Buy" and an average price target of $286.80.

Check Out Our Latest Analysis on DHR

Danaher Stock Performance

NYSE:DHR opened at $237.78 on Thursday. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. Danaher Co. has a twelve month low of $222.53 and a twelve month high of $281.70. The firm has a market cap of $171.74 billion, a price-to-earnings ratio of 45.38, a price-to-earnings-growth ratio of 4.23 and a beta of 0.83. The company has a 50-day moving average of $235.27 and a 200-day moving average of $253.56.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.57 by $0.14. The business had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm's revenue was up 3.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.02 earnings per share. Analysts forecast that Danaher Co. will post 7.49 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be issued a dividend of $0.27 per share. The ex-dividend date is Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.45%. Danaher's dividend payout ratio (DPR) is presently 20.61%.

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR - Free Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Massive Market Moves Following Trump Win: Tesla, JP Morgan, & Bitcoin Soar

Massive Market Moves Following Trump Win: Tesla, JP Morgan, & Bitcoin Soar

MarketBeat analyst Thomas Hughes breaks down the biggest winners of the day, including Tesla, JP Morgan, and the Russell 2000, and why they’re surging.

Recent Videos

Investing in Quantum Computing: Is Rigetti the Stock to Watch?
Affordable AI Stocks: 7 Picks Under $50
2025 Natural Gas Comeback: 3 Stocks Poised for Big Gains

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines